Form D · Other Health Care
PreciseDx, Inc.
New York, NY · CIK 0002013833
Offering snapshot reported Oct 7, 2026 · SEC filing
- Reported sold
- $3.7M Offering amount: $3.7M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 23, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 7, 2026 | Initial | $3,699,998 | No comparison | 9 | SEC filing |
| Jun 6, 2025 | Initial | $11,230,074 | No comparison | 9 | SEC filing |
| Apr 3, 2024 | Amendment | $20,720,678 | $0vs Apr 1, 2024 | 10 | SEC filing |
| Apr 1, 2024 | Initial | $20,720,678 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-600316
Source: Form D, filed Oct 7, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Wayne Brinster | Director, Executive |
| Eric Converse | Director, Executive |
| Westley Dupray | Director |
| Molly Harper | Director |
| Michael Hennessy Jr. | Director |
| Erik Lium | Director |
| Paul Roma | Director |
| Edward Joseph Sitar | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
810 7 Th Avenue Suite 515
New York, NY, 10019
New York, NY, 10019